卡莫富尔通过降低泰莫索洛米德耐药性质母细胞细胞中的E2F8转录来阻止细胞循环的进展
Cyntanna C Hawkins1, Amber B Jones1, Emily R Gordon2
1Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
Cell death discovery
|December 12, 2023
概括
卡莫富尔通过抑制酸amidase (ASAH1),降低细胞生长和增加对temozolomide抗性GBM细胞的细胞亡来使质脂代谢正常化.
科学领域:
- 生物化学 生物化学
- 癌症生物学 癌症生物学
- 神经瘤学神经瘤学
背景情况:
- 脂代谢失调,以增加脂-1-酸盐 (S1P) 和减少胺为特征,促进癌细胞的存活.
- 质母细胞瘤 (GBM) 呈现这种脂质不平衡,这有助于其侵略性和对标准治疗,如temozolomide (TMZ) 的耐药性.
- 向脂代谢为复发性GBM提供了潜在的治疗策略,目前尚无专门的治疗方法.
研究的目的:
- 调查酸胺酶 (ASAH1) 在耐泰莫佐洛米德抗 GBM 的作用.
- 为了评估卡尔摩的疗效,一个ASAH1抑制剂,在治疗耐TMZ的GBM细胞.
- 阐明卡尔摩在GBM中的作用背后的分子机制.
主要方法:
- 在复发性GBM中分析ASAH1mRNA水平.
- 治疗耐TMZ的GBM细胞使用carmofur.
- 评估细胞生长,细胞亡和细胞周期进展.
- 用RNA测序来识别受影响的途径和基因表达变化.
主要成果:
- 在复发性GBM中观察到高ASAH1mRNA.
- 卡尔莫富尔治疗减少了细胞生长,增加了耐TMZ的GBM细胞的细胞亡.
- RNA测序揭示了在TMZ耐药细胞中,卡尔莫富尔诱导的细胞循环控制通路的下调,包括E2F8.
结论:
- 在复发性GBM中,ASAH1被上调,其被卡尔摩抑制显示出治疗潜力.
- 卡莫富尔有效地降低了细胞增殖,并在耐TMZ的GBM细胞中诱导了细胞亡.
- 针对脂代谢,特别是通过ASAH1抑制和E2F8调节,可以克服TMZ在GBM中的耐药性.
相关概念视频
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K